Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Litigation practice is five-star social work: Justice AS Oka tells law students

We are packed and ready to move: Justice DY Chandrachud after controversy over official bungalow

Doing Business in India: Key Legal Hurdles for Foreign Companies

Supreme Court to hear petitions against Election Commission’s Bihar voter revision drive on July 10

'Bail is the rule' principle was forgotten; tried to reiterate it in Sisodia, Kavitha cases: CJI BR Gavai

SCROLL FOR NEXT